Rifabutin
- Product NDC
- 59762-1350
- 11-digit product format
- 597621350
- Labeler code
- 59762
- Product ID
- 59762-1350_25e74b16-cdf0-4959-be62-1745c4e4cf0a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- rifabutin
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Mylan Pharmaceuticals Inc.
- Application
- NDA050689
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2014-04-07
- Substance
- RIFABUTIN
- Active strength
- 150 mg/1
- Pharmacologic classes
- Rifamycin Antimycobacterial [EPC], Rifamycins [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Rifabutin
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| RIFABUTIN | 150 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 1W306TDA6S |
| Rxcui | 198200 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 59762-1350-1 | Rifabutin | 100 in 1 BOTTLE | CAPSULE | 100 | | 13 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 59762-1350 | RIFABUTIN CAPSULE [MYLAN PHARMACEUTICALS INC.] | 12 | Current NDC, Legacy NDC, 1 package rows | 20250523_c2026b67-4755-4236-96b6-a6b5e7399707.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 59762-1350-1 | 59762135001 | 100 CAPSULE in 1 BOTTLE (59762-1350-1) | 100 capsule | 2014-04-07 | 0000-00-00 | No | No | Current |